Viewing Study NCT04393506


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2025-12-29 @ 11:38 AM
Study NCT ID: NCT04393506
Status: COMPLETED
Last Update Posted: 2023-11-22
First Post: 2020-05-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Sponsor: Shanghai Jiao Tong University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module